Stock Updates

Is this Large Market Cap Stock target price reasonable for Celgene Corporation (NASDAQ:CELG)?

The company in question is, Celgene Corporation (NASDAQ:CELG) currently with a stock price of 98.5 (-2.12% today). The market cap for Celgene Corporation is 78000.18, and is in the sector Healthcare, and Biotechnology industry. The target price for Celgene Corporation is 137.35. Currently Celgene Corporation is trading with a P/E of 41.35, and a forward P/E of 14.09. Average volume for Celgene Corporation is 3966.29 and so far today it is 4309200.

Performance in the last year for Celgene Corporation has been -16.19%. For EPS growth, Celgene Corporation has seen a growth of -18.80%, and is looking to grow in the next year to 22.46%. More long term stats show that EPS growth has been 15.70% over the last five years and could be 21.87% for the next five years. Celgene Corporation has seen sales growth quarter over quarter at 20.90%, with EPS growth quarter over quarter at 72.90%. The 20-day simple moving average is -9.00%, with the 200-day simple moving average coming to -6.18%.

Since the IPO date for Celgene Corporation on the 3/26/1990, Celgene Corporation has seen performance year to date to be -17.75%. With Celgene Corporation trading at 98.5, the dividend yield is *TBA, and the EPS is 2.38.

So could Celgene Corporation, be undervalued? Well as said before P/E is 41.35. The PEG is 1.89, P/S is 7.67 and the P/B is at 13.78. The P/cash is 12.18, with P/free cash flow at 26.36.

Celgene Corporation ability to deal with debt shows that the current ratio is 4.6, and the quick ratio is 4.4. This is with long term debt/equity at 2.58, and total debt/equity at 0.

In terms of margins, Celgene Corporation has a gross margin of 95.70%, an operating margin of 27.10% and a profit margin of 18.90%.Payout ratio for Celgene Corporation is 0.00%. Return on assets come to 7.20% with return on investment coming to 8.90%.

Insider ownership for Celgene Corporation, is at 0.20% and institutional ownership comes to 79.10%. Outstanding shares are at 791.88. While shares float is 771.83. The float short is currently 1.06%, and short ratio is 2.06.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment